Header cover image
  • Investing Ideas
  • /
  • Romanian Pharmaceuticals & Biotech Strong Past Earnings Growth, P/E Ratio Below 20

Romanian Pharmaceuticals & Biotech Strong Past Earnings Growth, P/E Ratio Below 20

Results

1

0 new

A list of companies that grew earnings by 20% and are trading on less than 20 times earnings. All with a debt to equity ratio below 1.

1 companies

Zentiva

Market Cap: RON 3.2b

Engages in the production and marketing of preparations and medicines for human use in Romania and internationally.

SCD

RON 4.52

7D

0%

1Y

55.9%